Key result
H-FABP detected myocardial injury in 37% of patients 3 hours after percutaneous coronary intervention, which was more sensitive than cTnI and CK-MB.
Why the study?
Does H-FABP measurement improve the early detection of myocardial injury compared to cTnI and CK-MB in patients undergoing elective PCI?
Observational (n=40)
No
Does H-FABP measurement improve the early detection of myocardial injury compared to cTnI and CK-MB in patients undergoing elective PCI?
H-FABP is a more sensitive biomarker than cTnI and CK-MB for detecting early myocardial injury within 3 hours after elective percutaneous coronary intervention.
Answers are grounded in this paper and cite their sources.
H-FABP may enable earlier post-PCI injury detection than cTnI; leaves open clinical utility pending outcome studies.
Measurement of circulating cardiac biomarkers has enabled early diagnosis and risk assessment of acute coronary syndrome. Heart type fatty acid binding protein (H-FABP) is a relatively novel marker for the diagnosis of myocardial injury. The purpose of the present study was to compare H-FABP with Troponin I (cTnI) and creatine kinase myocardial band (CK-MB) in determining myocardial injury in patients with early stage of percutaneous coronary intervention (PCI). Blood was withdrawn one hour before and 3 hours after PCI from 40 patients to measure H-FABP, cTnI and CKMB. H-FABP was measured qualitatively. CK-MB and cTnI were measured by a sandwich enzyme-linked immunosorbent assay. Before PCI, H-FABP was found to be negative, while cTnI and CK-MB were found to be in normal ranges. Statistical analysis of measurements 3 hours after PCI revealed that H-FABP was significantly positive in 15 (37%) patients, while cTnI was elevated in 11 (27%) patients and CKMB was elevated in 8 (20%) patients. H-FABP is statistically more sensitive than cTnI and CK-MB at detecting myocardial injury after PCI.H-FABP can be used in early stages to detect myocardial injury caused by PCI. H-FABP is more sensitive than cTnI and CK-MB in determining myocardial injury due to PCI within 3 hours. H-FABP may help us stratify a patient's risk in early stages after PCI.
No takes yet. Share an insight, caveat, or question.
Özdemir et al. (2011) conducted an observational in Elective percutaneous coronary intervention (n=40). Heart type fatty acid binding protein (H-FABP) vs. Troponin I (cTnI) and Creatine kinase myocardial band (CK-MB) was evaluated on Detection of myocardial injury (biomarker elevation) 3 hours after PCI (p=0.046). H-FABP detected myocardial injury in 37% of patients 3 hours after percutaneous coronary intervention, which was more sensitive than cTnI and CK-MB.
Synapse has enriched 10 related papers. Consider them for comparative context: